Aickin M.

The phased approach to CAM research.

Program in Integrative Medicine, and Department of Family & Community Medicine, University of Arizona, Helfgott Research Institute, National College of Naturopathic Medicine, 4840 N Valley View Rd, Tucson, AZ 85718. maickin@earthlink.net

Research in several areas of biomedicine have benefited from categorizing studies according to their positions in a hierarchy, starting with small exploratory trials and proceeding through large-scale demonstration projects. Although most CAM/IM studies clearly belong to an early research phase, they are frequently designed, analyzed, and presented using the classical model of Phase III medical research (primarily the randomized clinical trial). The negative consequences of this practice will be delineated.

Definitions will be offered for appropriate phases of CAM/IM research, based on the models existing in other areas of biomedicine, consistent with opinions expressed by a broad, international collection of CAM/IM researchers. The general aims of the phases in this schema are:

Phase 0—to discover aspects of an approach that is little understood, or for which there is essentially no prior research.

Phase I—to find the practical problems and determine the fundamental feasibility of research on a particular approach.

Phase II—to test the solutions to problems that were uncovered, and to determine whether there is an indication of effectiveness that would justify further research.

Phase III—to compare the new CAM/IM approach with another (either CAM or non-CAM) approach, in order to declare when one is better than the other.

Phase IV—to investigate the magnitude of the deterioration of effect that happens with implementation outside a trial context; to estimate cost-effectiveness. Examples of articles will be presented that illustrate the points of these definitions.

Finally, an initiative will be described that has recently been taken by the Journal of Alternative and Complementary Medicine to encourage the conduct and publication of high-quality, early-phase CAM/IM research.

 

Back